Bausch Health Companies (TSE:BHC) Stock Price Down 1.2% – Here’s What Happened

Shares of Bausch Health Companies Inc. (TSE:BHC) fell 1.2% during mid-day trading on Wednesday . The company traded as low as C$10.79 and last traded at C$10.90. 220,157 shares changed hands during mid-day trading, a decline of 43% from the average session volume of 385,579 shares. The stock had previously closed at C$11.03.

Analysts Set New Price Targets

Separately, Raymond James upgraded Bausch Health Companies to a “hold” rating in a research note on Wednesday, July 10th.

Bausch Health Companies Price Performance

The company has a debt-to-equity ratio of 7,583.76, a current ratio of 1.19 and a quick ratio of 0.58. The stock’s fifty day moving average is C$8.98 and its 200-day moving average is C$9.99. The stock has a market capitalization of C$4.02 billion, a PE ratio of -6.38, a P/E/G ratio of 0.21 and a beta of 0.77.

Bausch Health Companies (TSE:BHC) last announced its quarterly earnings results on Thursday, August 1st. The company reported C$1.22 earnings per share for the quarter, meeting the consensus estimate of C$1.22. The firm had revenue of C$3.29 billion during the quarter, compared to analyst estimates of C$3.20 billion. Bausch Health Companies had a negative return on equity of 2,304.54% and a negative net margin of 5.12%. As a group, equities analysts predict that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current fiscal year.

Insider Buying and Selling at Bausch Health Companies

In related news, Senior Officer Seana Lynne Carson sold 13,370 shares of Bausch Health Companies stock in a transaction dated Friday, September 6th. The stock was sold at an average price of C$8.38, for a total value of C$112,087.40. Insiders own 11.28% of the company’s stock.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.